Form 8-K - Current report:
SEC Accession No. 0001493152-25-024156
Filing Date
2025-11-19
Accepted
2025-11-19 07:00:32
Documents
14
Period of Report
2025-11-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 44594
2 EX-10.1 ex10-1.htm EX-10.1 132932
3 EX-10.2 ex10-2.htm EX-10.2 47474
  Complete submission text file 0001493152-25-024156.txt   434243

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE aim-20251118.xsd EX-101.SCH 3014
5 XBRL LABEL FILE aim-20251118_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE aim-20251118_pre.xml EX-101.PRE 22359
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3566
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-27072 | Film No.: 251496612
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)